National Sickle Cell and Thalassemia Blood Group Genotyping Programme
Estimated value
£854k
Awarded value
£854k
Awarded 27 Jul 2023
Suppliers
1
Lots
1
1 awarded
Published
26 Sept 2023
Deadline 10 Jul 2023
Description
The proposed 12-month programme will enable genotyping of blood groups by NHS BT in current patients (up to 17,800 patients) with either sickle cell or thalassemia.
Scope
- Reference
- CF-1892100D0O000000rwimUAA
- Total value
- £854,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 27 Sept 2023 to 26 Jul 2024
- CPV classifications
- 85100000
Submission & procedure
- Submission deadline
- 10 Jul 2023, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£854k
Award date
27 Jul 2023
Contract start
27 Sept 2023
Contract end
26 Jul 2024
Awarded to